Abbott Laboratories (ABT)
NYSE: ABT · Real-Time Price · USD
104.71
-2.74 (-2.55%)
At close: Nov 17, 2026, 4:00 PM EST
105.77
+1.06 (1.01%)
Pre-market: Nov 18, 2026, 4:36 AM EST

Abbott Laboratories Stock Forecast

Stock Price Forecast

According to 28 analysts polled by S&P Global, Abbott Laboratories stock has a consensus rating of "Buy" and an average price target of $118.91. The average 1-year stock price forecast is 13.56% higher than the current stock price, while the lowest is $100 (-4.50%) and the highest is $130 (+24.15%).

Price Target: $118.91 (+13.56%)
Analyst Consensus: Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$100$118.91$120$130
Change-4.50%+13.56%+14.60%+24.15%

Analyst Ratings

The average analyst rating for Abbott Laboratories stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart
RatingJun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Strong Buy171617181818
Buy444455
Hold776555
Sell000000
Strong Sell000000
Total282727272828

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Bank of America Securities
Bank of America Securities
Buy
Maintains
$115 → $125
BuyMaintains$115 → $125+19.38%Nov 9, 2026
Piper Sandler
Piper Sandler
Buy
Maintains
$118
BuyMaintains$118+12.69%Nov 2, 2026
Argus Research
Argus Research
Hold
Downgrades
n/a
HoldDowngradesn/an/aOct 27, 2026
Evercore ISI
Evercore ISI
Buy
Maintains
$124 → $120
BuyMaintains$124 → $120+14.60%Oct 23, 2026
Stifel Nicolaus
Stifel Nicolaus
Buy
Maintains
$120
BuyMaintains$120+14.60%Oct 22, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
49.95B
from 44.33B
Increased by 12.67%
Revenue Next Year
53.50B
from 49.95B
Increased by 7.11%
EPS This Year
5.52
from 5.15
Increased by 7.16%
EPS Next Year
5.94
from 5.52
Increased by 7.58%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
43.08B43.65B40.11B41.95B44.33B49.95B
Revenue Growth
24.47%1.34%-8.12%4.59%5.67%12.67%
Gross Profit
25.00B24.57B22.19B23.31B25.12B28.67B
Gross Margin
58.03%56.28%55.32%55.56%56.66%57.40%
Operating Income
9.20B9.11B7.22B7.50B8.92B11.66B
Net Income
7.07B6.93B5.72B13.40B6.52B5.64B
EPS
----5.155.52
EPS Growth
----10.28%7.16%
Forward PE
30.0526.6424.2222.3922.6318.97
Dividend / Share
1.821.922.082.242.402.59
Dividend Growth
18.95%5.50%8.33%7.69%7.14%8.06%
Free Cash Flow
----7.40B8.18B
No. Analysts
-----25
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High50.1B
Avg49.9B
Low49.1B

Revenue Growth

Revenue Growth202620272028
High
13.1%
Avg
12.7%
Low
10.8%

EPS Forecast

EPS202620272028
High5.54
Avg5.52
Low5.49

EPS Growth

EPS Growth202620272028
High
7.6%
Avg
7.2%
Low
6.6%